SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
Clinical trial NCT03126461 · WITHDRAWN
Trial details
- NCT number
- NCT03126461
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2022-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.